Patents by Inventor Min Sung CHUNG

Min Sung CHUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CP2C-TARGETING PEPTIDE-BASED ANTICANCER AGENT
    Publication number: 20220160888
    Abstract: The presented invention relates to a CP2c-targeting peptide-based anticancer agent. A CP2c-targeting peptide according to the presented invention binds to transcription factor CP2c to inhibit the formation of transcription factor CP2c complexes (CP2c homotetramer and CP2c/CP2b/PIAS1 heterohexamer), thereby inducing cancer cell-specific cell death. A fatty acid is bound to the peptide to ensure stability enabling long-term sustenance in vivo.
    Type: Application
    Filed: April 1, 2020
    Publication date: May 26, 2022
    Applicants: Industry-University Cooperation Foundation Hanyang University, Konkuk University Glocal Industry-Academic Collaboration Foundation, Korea National University of Education Industry-Academy Cooperation Foundation
    Inventors: Chul Geun KIM, Min Young KIM, Chan Gil KIM, Seung Han SON, Ji Sook KIM, Sung Woo CHOI, Seol Eui LEE, Min Sung CHUNG, Dong Sun PARK, Sang Won LEE, Jae Min JEONG, Dong Ho CHOI, Ki Seok JANG